Eli Lilly Expects Up to $87 Billion in 2026 Revenue. Here's Why the Stock Still Looks Undervalued.

The Motley Fool | Oct 13, 2026 5:30 AM EDT

Key PointsEli Lilly dominates the weight loss drug market and is delivering explosive revenue growth.